| Autoimmune diseases associated with neuromyelitis optica spectrum disorders: a literature review S Shahmohammadi, R Doosti, A Shahmohammadi, ... Multiple sclerosis and related disorders 27, 350-363, 2019 | 167 | 2019 |
| Classification algorithms with multi-modal data fusion could accurately distinguish neuromyelitis optica from multiple sclerosis A Eshaghi, S Riyahi-Alam, R Saeedi, T Roostaei, A Nazeri, A Aghsaei, ... NeuroImage: Clinical 7, 306-314, 2015 | 55 | 2015 |
| Sleep disorder as a triggering factor for relapse in multiple sclerosis MA Sahraian, S Rezaali, M Hosseiny, R Doosti, A Tajik, ... European Neurology 77 (5-6), 258-261, 2017 | 37 | 2017 |
| EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature A Nejati, Z Shoja, S Shahmahmoodi, A Tafakhori, Y Mollaei-Kandelous, ... Medical microbiology and immunology 205, 143-154, 2016 | 36 | 2016 |
| Differential frequency of CD8+ T cell subsets in multiple sclerosis patients with various clinical patterns Z Salehi, R Doosti, M Beheshti, E Janzamin, MA Sahraian, M Izad PloS one 11 (7), e0159565, 2016 | 34 | 2016 |
| Neuromyelitis optica spectrum disorder (NMOSD) associated with cancer: a systematic review S Shahmohammadi, R Doosti, A Shahmohammadi, A Azimi, MA Sahraian, ... Multiple Sclerosis and Related Disorders 56, 103227, 2021 | 31 | 2021 |
| Channelopathy-related SCN10A gene variants predict cerebellar dysfunction in multiple sclerosis T Roostaei, S Sadaghiani, MTM Park, R Mashhadi, A Nazeri, S Noshad, ... Neurology 86 (5), 410-417, 2016 | 27 | 2016 |
| A presentation of ulcerative colitis after rituximab therapy in a patient with multiple sclerosis and literature review S Shahmohammadi, MA Sahraian, A Shahmohammadi, R Doosti, ... Multiple sclerosis and related disorders 22, 22-26, 2018 | 25 | 2018 |
| Convergent effects of a functional C3 variant on brain atrophy, demyelination, and cognitive impairment in multiple sclerosis T Roostaei, S Sadaghiani, R Mashhadi, M Falahatian, E Mohamadi, ... Multiple Sclerosis Journal 25 (4), 532-540, 2019 | 23 | 2019 |
| The expression of VDR mRNA but not NF-κB surprisingly decreased after vitamin D treatment in multiple sclerosis patients Z Shirvani-Farsani, MP Kakhki, BN Gargari, R Doosti, AN Moghadasi, ... Neuroscience Letters 653, 258-263, 2017 | 19 | 2017 |
| Quantitative evaluation of BAFF, HMGB1, TLR 4 AND TLR 7 expression in patients with relapsing remitting multiple sclerosis KM Hamid, A Nejati, Z Shoja, Y Mollaei-Kandelousd, R Doosti, ... Iranian Journal of Allergy, Asthma and Immunology, 75-81, 2016 | 18 | 2016 |
| A randomized controlled trial investigating the effects of a mediterranean-like diet in patients with multiple sclerosis-associated cognitive impairments and fatigue S Razeghi-Jahromi, R Doosti, Z Ghorbani, R Saeedi, M Abolhasani, ... Current Journal of Neurology 19 (3), 112, 2020 | 16 | 2020 |
| Widespread disruptions of white matter in familial multiple sclerosis: DTI and NODDI study Z Gharaylou, MA Sahraian, M Hadjighassem, M Kohanpour, R Doosti, ... Frontiers in Neurology 12, 678245, 2021 | 13 | 2021 |
| Molecular detection of epstein–barr virus, human herpes virus 6, cytomegalovirus, and hepatitis b virus in patients with multiple sclerosis M Asouri, MA Sahraian, M Karimpoor, S Fattahi, N Motamed, R Doosti, ... Middle East journal of digestive diseases 12 (3), 171, 2020 | 12 | 2020 |
| Analysis of single nucleotide polymorphisms in HLA-DRA, IL2RA, and HMGB1 genes in multiple sclerosis M Asouri, HA Rokni, MA Sahraian, S Fattahi, N Motamed, R Doosti, ... Reports of Biochemistry & Molecular Biology 9 (2), 198, 2020 | 10 | 2020 |
| Evaluation of the risk of cervical cancer in patients with Multiple Sclerosis treated with cytotoxic agents: A cohort study MAS Rozita Doosti, Mansoureh Togha, Abdorreza Naser Moghadasi, Aida Aghsaei ... Iranian Journal of Neurology 17 (No 2), 2018 | 10 | 2018 |
| Relationship between NF-κB1− 94 ins/del ATTG polymorphism and susceptibility of multiple sclerosis in Iranian MS patients H Zahednasab, SA Mesbah-Namin, MA Sahraian, M Balood, R Doosti Neuroscience Letters 545, 46-49, 2013 | 7 | 2013 |
| Psychometric properties of the persian version of the PARADISE-24 questionnaire A Azimi, R Doosti, SMV Samani, B Roostaei, SH Gashti, S Navardi, ... International journal of preventive medicine 12 (1), 50, 2021 | 6 | 2021 |
| Safety and efficacy of fingolimod in Iranian patients with relapsing-remitting multiple sclerosis: An open-label study R Doosti, AN Moghadasi, AR Azimi, SK Saleh, M Etemadifar, ... Caspian Journal of Internal Medicine 12 (3), 263, 2021 | 4 | 2021 |
| Is anemia a probable cause of fatigue in patients with multiple sclerosis? S Mir-Reza, M Tabatabaeiyan, R Doosti, M Owji, AN Moghadasi Iranian journal of neurology 12 (1), 35, 2013 | 4 | 2013 |
Abdorreza Naser MoghadasiNeurologist, MS Research Center在 sina.tums.ac.ir 的电子邮件经过验证
